ABEO
Abeona Therapeutics Inc
NASDAQ: ABEO · HEALTHCARE · BIOTECHNOLOGY
$5.34
-0.37% today
Updated 2026-04-29
Market cap
$303.75M
P/E ratio
5.29
P/S ratio
52.19x
EPS (TTM)
$1.01
Dividend yield
—
52W range
$4 – $8
Volume
1.2M
WallStSmart proprietary scores
46
out of 100
Grade: C
Sell
Investment rating
5.3
Growth
C+5.0
Quality
C+6.0
Profitability
B8.3
Valuation
A—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$19.57
+266.48%
12-Month target
$4.42
-17.23%
Intrinsic (DCF)
$27.73
Margin of safety
+81.75%
0 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 1,223.00% — above average
+ ROE 70.10% — strong efficiency
+ 81.75% below intrinsic value
Risks
- Negative free cash flow $-19.11M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.41M | $3.50M | $0.00 | $5.82M | $5.82M |
| Net income | $-39.70M | $-54.19M | $-63.73M | $71.18M | $-20.46M |
| EPS | — | — | — | — | $1.01 |
| Free cash flow | $-43.61M | $-37.34M | $-58.46M | $-84.30M | $-19.11M |
| Profit margin | -2,807.36% | -1,548.23% | — | 1,223.08% | 1,223.00% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-31 | SESHADRI, VISHWAS | Sale | 29,985 | $4.38 |
| 2026-03-16 | VAZZANO, JOSEPH WALTER | Sale | 785 | $4.76 |
| 2026-02-02 | WUCHTERL, DONALD A. | Sale | 14,814 | $5.09 |
Peer comparison
Smart narrative
Abeona Therapeutics Inc trades at $5.34. representing a P/E of 5.29x trailing earnings. Our Smart Value Score of 46/100 indicates the stock is fair. TTM revenue stands at $5.82M. with profit margins at 1,223.00%. Our DCF model estimates intrinsic value at $27.73.
Frequently asked questions
What is Abeona Therapeutics Inc's stock price?
Abeona Therapeutics Inc (ABEO) trades at $5.34.
Is Abeona Therapeutics Inc overvalued?
Smart Value Score 46/100 (Grade C, Sell). DCF value $27.73.
What is the price target of Abeona Therapeutics Inc (ABEO)?
The analyst target price is $19.57, representing +266.5% upside from the current price of $5.34.
What is the intrinsic value of Abeona Therapeutics Inc (ABEO)?
Based on our DCF model, intrinsic value is $27.73, a +81.8% margin of safety versus $5.34.
What is Abeona Therapeutics Inc's revenue?
TTM revenue is $5.82M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio52.19x
ROE70.10%
Beta1.21
50D MA$4.98
200D MA$5.42
Shares out0.06B
Float0.04B
Short ratio—
Avg volume1.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—